U.S. Physical Therapy Quarterly Income Statements Chart
Quarterly
|
Annual
U.S. Physical Therapy Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2018-12-31 | 2017-12-31 | 2014-09-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| net patient revenue | 164,183,000 | 152,547,000 | 102,623,000 | 139,146,000 | 140,271,000 | 131,452,000 | 127,243,000 | 120,146,000 | 116,710,000 | 118,196,000 | 109,538,000 | 113,511,000 | 112,327,000 | ||||||||||||||||||||||||||||||||||
| other revenue | 33,161,000 | 31,241,000 | 20,101,500 | 28,887,000 | 26,919,000 | 23,349,000 | 22,764,000 | 21,036,000 | 22,892,000 | 22,460,000 | 22,166,000 | 16,322,000 | 13,566,000 | ||||||||||||||||||||||||||||||||||
| net revenue | 197,344,000 | 183,788,000 | 122,724,500 | 168,033,000 | 167,190,000 | 154,801,000 | 150,007,000 | 141,182,000 | 139,602,000 | 140,656,000 | 131,704,000 | 129,833,000 | 125,893,000 | ||||||||||||||||||||||||||||||||||
| operating cost: | |||||||||||||||||||||||||||||||||||||||||||||||
| salaries and related costs | 113,788,000 | 111,249,000 | 72,475,000 | 99,835,000 | 96,334,000 | 90,633,000 | 89,846,000 | 82,317,000 | 81,786,000 | 79,939,000 | 75,149,000 | 75,296,000 | 70,492,000 | 68,866,000 | 63,815,000 | 65,677,000 | 57,519,000 | 43,429,000 | 69,004,000 | 70,549,000 | 66,748,000 | 70,669,000 | 117,214,000 | 41,802,000 | 37,942,000 | 36,522,000 | 35,733,000 | 35,813,000 | 34,415,000 | 33,978,000 | 33,376,000 | 32,671,000 | 32,799,000 | 31,928,000 | 32,430,000 | 31,120,000 | 29,639,000 | 27,991,000 | 27,644,000 | 26,771,000 | 26,823,000 | 26,430,000 | 25,403,000 | 25,686,000 | 25,661,000 | 24,821,000 | |
| rent, supplies, contract labor and other | 34,127,000 | 33,844,000 | 25,107,500 | 33,914,000 | 35,277,000 | 32,080,000 | 30,707,000 | 29,678,000 | 29,696,000 | 28,345,000 | 28,662,000 | 25,961,000 | 24,239,000 | 22,416,000 | 21,420,000 | 21,421,000 | 19,695,000 | 20,311,000 | 22,909,000 | 23,143,000 | 22,166,000 | 23,026,000 | |||||||||||||||||||||||||
| depreciation and amortization | 5,741,000 | 5,540,000 | |||||||||||||||||||||||||||||||||||||||||||||
| benefit from credit losses | 1,995,000 | 1,848,000 | 1,266,250 | 1,721,000 | 1,717,000 | 1,572,000 | 1,525,000 | 1,356,000 | 1,336,000 | 1,551,000 | 1,305,000 | 1,383,000 | 1,358,000 | 1,364,000 | 1,200,000 | ||||||||||||||||||||||||||||||||
| clinic closure costs - lease and other | 69,000 | 242,000 | 1,027,250 | 3,432,000 | |||||||||||||||||||||||||||||||||||||||||||
| total operating cost | 155,720,000 | 152,723,000 | 99,876,000 | 138,902,000 | 133,328,000 | 124,285,000 | 122,078,000 | 113,351,000 | 112,818,000 | 109,835,000 | 105,116,000 | 102,650,000 | 96,094,000 | ||||||||||||||||||||||||||||||||||
| gross profit | 41,624,000 | 31,065,000 | 22,848,500 | 29,131,000 | 33,862,000 | 30,516,000 | 27,929,000 | 27,831,000 | 26,784,000 | 30,821,000 | 26,588,000 | 27,183,000 | 29,799,000 | 34,304,000 | 25,896,000 | 29,118,000 | 30,357,000 | 19,284,000 | 15,691,000 | 26,959,000 | 27,372,000 | 31,425,000 | |||||||||||||||||||||||||
| yoy | 22.92% | 1.80% | -18.19% | 4.67% | 26.43% | -0.99% | 5.04% | 2.38% | -10.12% | -10.15% | 2.67% | -6.65% | -1.84% | 77.89% | 65.04% | 8.01% | 10.91% | -38.63% | |||||||||||||||||||||||||||||
| qoq | 33.99% | 35.96% | -21.57% | -13.97% | 10.96% | 9.26% | 0.35% | 3.91% | -13.10% | 15.92% | -2.19% | -8.78% | -13.13% | 32.47% | -11.07% | -4.08% | 57.42% | 22.90% | -41.80% | -1.51% | -12.90% | ||||||||||||||||||||||||||
| gross margin % | |||||||||||||||||||||||||||||||||||||||||||||||
| corporate office costs | 17,476,000 | 16,245,000 | 10,679,750 | 14,385,000 | 14,249,000 | 13,901,000 | 12,048,000 | 11,925,000 | 11,889,000 | 10,741,000 | 11,556,000 | 10,718,000 | 12,867,000 | 12,074,000 | 10,874,000 | 10,916,000 | 10,422,000 | 9,022,000 | 11,677,000 | 11,673,000 | 10,556,000 | 11,527,000 | 13,675,000 | 7,468,000 | 7,132,000 | 6,766,000 | 6,224,000 | 6,622,000 | 6,507,000 | 6,147,000 | 5,977,000 | 6,396,000 | 6,262,000 | 7,088,000 | 5,142,000 | 6,007,000 | 6,481,000 | 5,798,000 | 5,511,000 | 5,805,000 | 5,790,000 | 6,234,000 | 5,388,000 | 5,052,000 | 4,677,000 | 5,431,000 | |
| (gain) loss on change in fair value of contingent earn-out consideration | -790,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| operating income | 24,938,000 | 19,642,000 | 12,168,750 | 14,746,000 | 19,613,000 | -880,000 | 15,881,000 | 6,794,000 | 14,895,000 | 20,080,000 | 15,032,000 | 16,465,000 | 16,932,000 | 22,230,000 | 15,022,000 | 18,202,000 | 19,935,000 | 10,262,000 | 4,014,000 | 15,286,000 | 16,816,000 | 19,898,000 | 10,684,000 | 8,151,000 | 7,942,000 | 9,392,000 | 10,598,000 | 9,871,000 | 7,715,000 | 8,652,000 | 10,882,000 | 8,682,000 | 8,733,000 | 9,990,000 | 6,666,000 | 7,195,000 | 8,487,000 | 6,457,000 | |||||||||
| yoy | 27.15% | -2332.05% | -23.38% | 117.04% | 31.68% | -104.38% | 5.65% | -58.74% | -12.03% | -9.67% | 0.07% | -9.54% | -15.06% | 116.62% | 274.24% | 19.08% | 18.55% | -48.43% | 0.81% | -17.42% | 2.94% | 8.55% | -2.61% | 13.70% | -11.66% | -13.39% | 63.25% | 20.67% | 2.90% | 54.72% | |||||||||||||||||
| qoq | 26.96% | 61.41% | -17.48% | -24.82% | -2328.75% | -105.54% | 133.75% | -54.39% | -25.82% | 33.58% | -8.70% | -2.76% | -23.83% | 47.98% | -17.47% | -8.69% | 94.26% | 155.66% | -73.74% | -9.10% | -15.49% | 31.08% | 2.63% | -15.44% | -11.38% | 7.37% | 27.95% | -10.83% | -20.49% | 25.34% | -0.58% | -12.58% | 49.86% | -7.35% | -15.22% | 31.44% | |||||||||||
| operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||
| other income: | |||||||||||||||||||||||||||||||||||||||||||||||
| interest expense, debt and other | -2,422,000 | -2,279,000 | -1,491,500 | -2,018,000 | -1,980,000 | -2,010,000 | -2,101,000 | ||||||||||||||||||||||||||||||||||||||||
| interest income from investments | 28,000 | 24,000 | 908,750 | 1,018,000 | 1,074,000 | ||||||||||||||||||||||||||||||||||||||||||
| change in revaluation of put-right liability | -339,000 | -404,000 | -34,000 | 168,000 | -223,000 | 2,926,000 | -145,000 | ||||||||||||||||||||||||||||||||||||||||
| equity in earnings of unconsolidated affiliate | 401,000 | 393,000 | 187,500 | 231,000 | 248,000 | 149,000 | 206,000 | 192,000 | 304,000 | 340,000 | 339,000 | ||||||||||||||||||||||||||||||||||||
| loss on sale of a partnership | -123,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| other | 47,000 | 75,000 | 65,250 | 90,000 | 109,000 | 85,000 | 78,000 | ||||||||||||||||||||||||||||||||||||||||
| total other income | -2,285,000 | -2,314,000 | -1,697,000 | -2,410,000 | -4,818,000 | 986,000 | -102,000 | ||||||||||||||||||||||||||||||||||||||||
| income before taxes | 22,653,000 | 17,328,000 | 10,471,750 | 12,336,000 | 14,795,000 | 106,000 | 15,779,000 | 4,560,000 | 16,036,000 | 19,495,000 | 15,480,000 | 13,701,750 | 17,938,000 | 22,039,000 | 14,830,000 | 23,196,000 | 20,042,000 | 18,645,000 | 3,630,000 | 14,439,000 | 16,266,000 | 25,118,000 | 10,555,000 | 7,354,000 | 9,251,000 | 10,454,000 | 9,711,000 | 6,973,250 | 8,507,000 | 10,775,000 | 8,611,000 | 8,684,000 | 9,911,000 | 7,182,000 | |||||||||||||
| benefit from income taxes | 4,933,000 | 3,860,000 | 2,195,250 | 2,559,000 | 3,083,000 | 1,399,000 | 3,557,000 | 1,212,000 | 3,215,000 | 4,239,000 | 3,498,000 | 3,946,000 | 3,815,000 | 4,567,000 | 2,944,000 | 4,569,000 | 4,279,000 | 3,882,000 | 292,000 | 2,424,000 | 3,197,000 | 5,318,000 | -5,001,000 | 3,625,000 | 2,939,000 | 3,438,000 | 3,017,000 | 3,181,000 | 2,409,000 | 2,042,000 | 2,953,000 | 3,140,000 | 2,899,000 | 2,845,000 | 2,654,000 | 3,172,000 | 2,426,000 | 2,507,000 | 2,877,000 | 2,051,000 | 1,964,000 | 2,342,000 | 1,779,000 | 1,451,000 | 1,635,000 | 1,863,000 | |
| net income | 17,720,000 | 13,468,000 | 8,276,500 | 9,777,000 | 11,712,000 | -1,293,000 | 12,222,000 | 3,348,000 | 12,821,000 | 15,256,000 | 11,982,000 | 14,443,000 | 14,123,000 | 17,472,000 | 11,886,000 | 18,627,000 | 15,763,000 | 14,763,000 | 3,338,000 | 12,015,000 | 13,069,000 | 19,800,000 | 2,233,000 | 2,531,000 | 2,855,000 | ||||||||||||||||||||||
| yoy | 51.30% | -1141.61% | -32.28% | 192.03% | -8.65% | -108.48% | 2.00% | -76.82% | -9.22% | -12.68% | 0.81% | -22.46% | -10.40% | 18.35% | 256.08% | 55.03% | 20.61% | -25.44% | |||||||||||||||||||||||||||||
| qoq | 31.57% | 62.73% | -15.35% | -16.52% | -1005.80% | -110.58% | 265.05% | -73.89% | -15.96% | 27.32% | -17.04% | 2.27% | -19.17% | 47.00% | -36.19% | 18.17% | 6.77% | 342.27% | -72.22% | -8.06% | -33.99% | -11.77% | -11.35% | ||||||||||||||||||||||||
| net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||
| less: net income attributable to non-controlling interest: | |||||||||||||||||||||||||||||||||||||||||||||||
| redeemable non-controlling interest - temporary equity | -3,914,000 | -2,012,000 | -1,884,750 | -1,998,000 | -3,314,000 | 3,190,000 | -1,976,000 | 318,000 | -2,037,000 | -2,626,000 | -2,557,000 | -2,689,000 | -2,605,000 | ||||||||||||||||||||||||||||||||||
| non-controlling interest - permanent equity | -1,413,000 | -1,557,000 | -846,750 | -1,151,000 | -892,000 | -1,241,000 | -992,000 | -1,059,000 | -1,227,000 | -1,435,000 | -626,000 | -1,541,000 | -1,509,000 | ||||||||||||||||||||||||||||||||||
| net income attributable to usph shareholders | 12,393,000 | 9,899,000 | 5,545,000 | 6,628,000 | 7,506,000 | 656,000 | 9,254,000 | 2,607,000 | 9,557,000 | 11,195,000 | 8,799,000 | 10,213,000 | 10,009,000 | 12,436,000 | 8,173,000 | 13,030,000 | 10,916,000 | 10,232,000 | 1,016,000 | 7,929,000 | 9,047,000 | 14,620,000 | |||||||||||||||||||||||||
| basic and diluted earnings per share attributable to usph shareholders | 0.58 | 0.8 | 0.33 | 0.39 | 0.47 | -0.44 | 0.51 | -0.02 | 0.72 | 0.87 | 0.67 | 0.72 | 0.66 | 0.82 | 0.21 | 0.68 | 0.61 | 0.99 | 0.2 | 0.55 | 0.66 | 0.85 | |||||||||||||||||||||||||
| shares used in computation - basic and diluted | 15,197 | 15,132 | 3,763.75 | 15,077 | 15,072 | 270 | 14,987 | 6 | 13,001 | 12,998 | 12,937 | 4 | 12,909 | 12,902 | 12,870 | 6 | 12,847 | 12,843 | 12,796 | 6 | 12,774 | 12,767 | |||||||||||||||||||||||||
| dividends declared per common share | 0.45 | 0.45 | 0.33 | 0.44 | 0.44 | 0.43 | 0.43 | 0.41 | 0.41 | 0.41 | 0.41 | 0.38 | 0.38 | 0.35 | 0.35 | 0.32 | 0.3 | 0.3 | 0.27 | 0.44 | 0.12 | 0.12 | 0.1 | 0.1 | 0.1 | 0.1 | 0.49 | 0.09 | 0.09 | 0.09 | 0.06 | 0.08 | 0.08 | 0.08 | |||||||||||||
| gain on change in fair value of contingent earn-out consideration | -4,822,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| other income | |||||||||||||||||||||||||||||||||||||||||||||||
| change in fair value of contingent earn-out consideration | -1,333,000 | -1,899,000 | -4,046,000 | -1,747,000 | 187,000 | 520,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||
| relief funds | 5,152,000 | 390,000 | 7,959,000 | ||||||||||||||||||||||||||||||||||||||||||||
| interest income | 547,750 | 1,673,000 | 3,000 | ||||||||||||||||||||||||||||||||||||||||||||
| other income and expense | |||||||||||||||||||||||||||||||||||||||||||||||
| resolution of a payor matter | 1,216,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| interest and other income | 69,000 | 65,000 | 679,000 | 46,000 | 41,000 | 58,000 | 46,000 | 54,000 | 45,000 | 50,000 | 4,000 | 43,000 | 19,000 | 7,000 | 4,000 | 85,000 | 2,000 | 1,000 | 2,000 | 2,000 | 1,000 | 2,000 | 2,000 | 1,000 | 1,000 | 2,000 | 5,437,000 | 4,000 | 2,000 | 2,000 | 1,000 | 2,000 | 580,000 | 2,000 | 2,000 | ||||||||||||
| gain on revaluation of put-right liability | 192,750 | 785,000 | 603,000 | ||||||||||||||||||||||||||||||||||||||||||||
| interest expense - debt and other | -2,239,000 | -2,013,000 | -987,000 | -540,000 | -191,000 | -268,000 | -237,000 | -246,000 | -203,000 | -351,000 | -653,000 | -427,000 | |||||||||||||||||||||||||||||||||||
| total other income and expense | -2,234,000 | 1,141,000 | -585,000 | 448,000 | 1,924,000 | 1,006,000 | -191,000 | -192,000 | 4,994,000 | 107,000 | 8,383,000 | ||||||||||||||||||||||||||||||||||||
| loss on revaluation of put-right liability | -617,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| closure costs - lease and other | 10,000 | 5,000 | -22,000 | 37,000 | 6,000 | 79,000 | 94,000 | 1,893,000 | |||||||||||||||||||||||||||||||||||||||
| closure costs - derecognition of goodwill | |||||||||||||||||||||||||||||||||||||||||||||||
| other income and expense: | |||||||||||||||||||||||||||||||||||||||||||||||
| gain on sale of partnership interest and clinics | 18,000 | 1,073,000 | |||||||||||||||||||||||||||||||||||||||||||||
| net patient revenues | 113,238,000 | 99,254,000 | 104,537,000 | 96,398,000 | 72,279,000 | 100,126,000 | 108,940,000 | 104,392,000 | 113,363,000 | 168,175,000 | 76,184,000 | 68,397,000 | 67,256,000 | 64,368,000 | 65,295,000 | 61,505,000 | 61,110,000 | 60,782,000 | 62,052,000 | 60,499,000 | 58,697,000 | 57,332,000 | 56,678,000 | 53,872,000 | 51,748,000 | 52,296,000 | 48,779,000 | 49,578,000 | 50,291,000 | 46,664,000 | 46,409,000 | 46,128,000 | 46,205,000 | ||||||||||||||
| other revenues | 13,690,000 | 13,114,000 | 12,929,000 | 12,531,000 | 11,578,000 | 12,591,000 | 13,174,000 | 12,859,000 | 13,010,000 | 20,192,000 | 1,532,000 | 1,370,000 | 1,349,000 | 1,461,000 | 1,929,000 | 1,593,000 | 1,584,000 | 2,071,000 | 1,907,000 | 2,083,000 | 1,981,000 | 2,343,000 | 3,234,000 | 2,869,000 | |||||||||||||||||||||||
| net revenues | 126,928,000 | 112,368,000 | 117,466,000 | 108,929,000 | 83,857,000 | 112,717,000 | 122,114,000 | 117,251,000 | 126,373,000 | 188,367,000 | 77,716,000 | 69,767,000 | 68,605,000 | 65,829,000 | 67,224,000 | 63,098,000 | 62,694,000 | 62,853,000 | 63,959,000 | 62,582,000 | 60,678,000 | 59,675,000 | 59,912,000 | 56,741,000 | 53,398,000 | 54,103,000 | 50,405,000 | 51,037,000 | 51,787,000 | 48,169,000 | 47,814,000 | 47,232,000 | 47,389,000 | ||||||||||||||
| operating costs: | |||||||||||||||||||||||||||||||||||||||||||||||
| total operating costs | 92,624,000 | 86,472,000 | 88,348,000 | 78,572,000 | 64,573,000 | 97,026,000 | 95,155,000 | 89,879,000 | 94,948,000 | ||||||||||||||||||||||||||||||||||||||
| less: net income attributable to non-controlling interests: | |||||||||||||||||||||||||||||||||||||||||||||||
| redeemable non-controlling interests - temporary equity | -3,611,000 | -2,453,000 | -3,364,000 | -3,019,000 | -2,996,000 | -1,796,000 | -2,507,000 | -2,379,000 | -3,378,000 | ||||||||||||||||||||||||||||||||||||||
| non-controlling interests - permanent equity | -1,425,000 | -1,260,000 | -2,233,000 | -1,828,000 | -1,535,000 | -526,000 | -1,579,000 | -1,643,000 | -1,802,000 | ||||||||||||||||||||||||||||||||||||||
| benefit from doubtful accounts | 844,750 | 1,279,000 | 739,000 | 1,361,000 | 1,450,000 | 962,000 | 1,240,000 | 578,000 | 1,090,000 | 950,000 | 994,000 | 1,095,000 | 1,193,000 | 1,089,000 | 1,192,000 | 1,259,000 | 1,280,000 | 1,117,000 | 1,231,000 | 1,426,000 | 504,000 | 624,000 | 695,000 | 734,000 | 1,034,000 | 1,001,000 | 869,000 | 706,000 | 843,000 | 747,000 | 735,000 | ||||||||||||||||
| closure costs - write-off of goodwill | 1,859,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| closure costs | 13,000 | 3,000 | 13,000 | 627,000 | -39,000 | 13,000 | 225,000 | -5,000 | 8,000 | 18,000 | 135,000 | 5,000 | 22,000 | 49,000 | 15,000 | 13,000 | 11,000 | 20,000 | 19,000 | -14,000 | 29,000 | 49,000 | 32,000 | 2,000 | |||||||||||||||||||||||
| gain on sale of partnership interest | -309,000 | 5,823,000 | |||||||||||||||||||||||||||||||||||||||||||||
| interest expense | -380,500 | -557,000 | -607,000 | -205,500 | -237,000 | -253,000 | -140,000 | -133,000 | -130,000 | -135,000 | -108,000 | -142,000 | -145,000 | -162,000 | -165,000 | -149,000 | -109,000 | -73,000 | -50,000 | -81,000 | -64,000 | -93,000 | -113,000 | -88,000 | -121,000 | -158,000 | -114,000 | ||||||||||||||||||||
| clinic operating costs: | |||||||||||||||||||||||||||||||||||||||||||||||
| rent, clinic supplies, contract labor and other | 11,384,500 | 16,117,000 | 14,216,000 | 14,726,000 | 12,878,000 | 12,904,000 | 12,918,000 | 13,300,000 | 12,844,000 | 12,992,000 | 12,484,000 | 12,701,000 | 12,012,000 | 11,388,000 | 11,295,000 | 10,162,000 | 10,238,000 | 10,100,000 | 10,179,000 | 9,735,000 | 10,213,000 | 10,153,000 | 10,216,000 | 9,842,000 | |||||||||||||||||||||||
| total clinic operating costs | 42,114,250 | 58,970,000 | 53,121,000 | 52,467,000 | 49,701,000 | 49,918,000 | 48,440,000 | 48,605,000 | 47,484,000 | 46,965,000 | 46,449,000 | 45,875,000 | 45,881,000 | 43,023,000 | 41,578,000 | 38,867,000 | 38,602,000 | 37,934,000 | 38,052,000 | ||||||||||||||||||||||||||||
| gross margin | 14,306,750 | 18,746,000 | 16,646,000 | 16,138,000 | 16,128,000 | 17,306,000 | 14,658,000 | 14,089,000 | 15,369,000 | 16,994,000 | |||||||||||||||||||||||||||||||||||||
| operating income from continuing operations | 8,753,250 | 11,278,000 | 9,514,000 | 9,372,000 | 9,904,000 | 5,648,000 | 5,931,000 | 6,560,000 | |||||||||||||||||||||||||||||||||||||||
| income before taxes from continuing operations | 8,548,500 | 11,043,000 | 9,262,000 | 9,234,000 | 9,773,000 | ||||||||||||||||||||||||||||||||||||||||||
| net income from continuing operations including non-controlling interests | 5,790,250 | 7,418,000 | 6,323,000 | 5,796,000 | 6,756,000 | ||||||||||||||||||||||||||||||||||||||||||
| discontinued operations, net of tax | -1,241,250 | -4,497,000 | |||||||||||||||||||||||||||||||||||||||||||||
| net income including non-controlling interests | 5,790,250 | 7,418,000 | 6,323,000 | 5,754,000 | 2,259,000 | ||||||||||||||||||||||||||||||||||||||||||
| less: net income attributable to non-controlling interests | 1,817,000 | -2,202,000 | -2,095,000 | -1,893,000 | -2,032,000 | ||||||||||||||||||||||||||||||||||||||||||
| net income attributable to common shareholders | 3,969,000 | 5,216,000 | 4,228,000 | 3,861,000 | 227,000 | 4,914,000 | 3,721,000 | 4,043,000 | 4,563,000 | 4,849,000 | 4,478,000 | 8,229,000 | 4,099,000 | 4,900,000 | 3,746,000 | 3,875,000 | 4,451,000 | 3,172,000 | 3,101,000 | ||||||||||||||||||||||||||||
| diluted earnings per share attributable to common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||
| from continuing operations | 0.325 | 0.43 | 0.35 | 0.32 | 0.38 | ||||||||||||||||||||||||||||||||||||||||||
| basic earnings per share attributable to common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||
| revaluation of redeemable non-controlling interests, net of tax | -0.023 | -0.08 | |||||||||||||||||||||||||||||||||||||||||||||
| from discontinued operations | -0.01 | -0.36 | |||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.303 | 0.43 | 0.31 | 0.02 | |||||||||||||||||||||||||||||||||||||||||||
| diluted | 0.303 | 0.43 | |||||||||||||||||||||||||||||||||||||||||||||
| shares used in computation: | |||||||||||||||||||||||||||||||||||||||||||||||
| basic | 3,050.25 | 12,244 | 12,129 | 13 | 12,106 | 12,089 | 11,955 | 26 | 11,827 | 11,781 | 11,726 | -10 | 11,886 | 11,807 | 11,718 | 11,667 | 11,622 | 11,614 | 11,570 | 11,615 | 12,020 | ||||||||||||||||||||||||||
| diluted | 3,052 | 12,247 | 12,144 | 13 | 12,120 | 12,110 | 11,979 | 12 | 11,928 | 11,903 | 11,838 | -30 | 12,011 | 11,999 | 11,945 | 11,889 | 11,857 | 11,840 | 11,748 | 11,653 | 12,025 | ||||||||||||||||||||||||||
| earnings attributable to common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||
| from discontinued operations | -0.01 | -0.36 | |||||||||||||||||||||||||||||||||||||||||||||
| from discontinued operations | -0.01 | -0.36 | |||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.303 | 0.43 | 0.31 | 0.02 | |||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per share attributable to common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 0.32 | 0.02 | |||||||||||||||||||||||||||||||||||||||||||||
| net income including noncontrolling interests | 7,374,000 | 5,609,000 | 5,794,000 | 6,298,000 | 7,314,000 | 6,812,000 | 10,142,000 | 5,853,000 | 7,603,000 | 6,185,000 | 6,177,000 | 7,034,000 | 5,131,000 | 5,140,000 | 6,034,000 | 4,593,000 | |||||||||||||||||||||||||||||||
| less: net income attributable to noncontrolling interests | -2,460,000 | -1,888,000 | -1,751,000 | -1,735,000 | -2,465,000 | -2,334,000 | -1,913,000 | -1,754,000 | -2,703,000 | -2,439,000 | -2,302,000 | -2,583,000 | -1,959,000 | -2,039,000 | |||||||||||||||||||||||||||||||||
| earnings per share attributable to common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.41 | 0.31 | 0.34 | 0.39 | 0.41 | 0.38 | 0.7 | 0.35 | 0.42 | 0.32 | 0.33 | 0.38 | 0.27 | 0.27 | 0.31 | ||||||||||||||||||||||||||||||||
| diluted | 0.41 | 0.31 | 0.34 | 0.38 | 0.41 | 0.38 | 0.69 | 0.34 | 0.41 | 0.31 | 0.33 | 0.38 | 0.27 | 0.26 | 0.31 | ||||||||||||||||||||||||||||||||
| income from operations | 8,018,000 | 7,104,000 | 8,376,000 | 6,372,000 | |||||||||||||||||||||||||||||||||||||||||||
| management contract revenues and other revenues | 1,650,000 | 1,807,000 | 1,626,000 | 1,459,000 | 1,496,000 | 1,505,000 | |||||||||||||||||||||||||||||||||||||||||
| less: net income attributable to noncontrolling interest | -2,412,000 | -1,839,000 | |||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to u. s. physical therapy, inc | 3,622,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| earnings per share attributable to u. s. physical therapy, inc. common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.41 | 0.31 | 0.34 | 0.39 | 0.41 | 0.38 | 0.7 | 0.35 | 0.42 | 0.32 | 0.33 | 0.38 | 0.27 | 0.27 | 0.31 | ||||||||||||||||||||||||||||||||
| diluted | 0.41 | 0.31 | 0.34 | 0.38 | 0.41 | 0.38 | 0.69 | 0.34 | 0.41 | 0.31 | 0.33 | 0.38 | 0.27 | 0.26 | 0.31 | ||||||||||||||||||||||||||||||||
| net income attributable to u. s. physical therapy, inc. | 2,754,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to u. s. physical therapy, inc. common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.23 | ||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 0.23 | ||||||||||||||||||||||||||||||||||||||||||||||
| management contract and other revenues | 835,500 | 1,104,000 | 1,184,000 | ||||||||||||||||||||||||||||||||||||||||||||
| interest, investment and other income | 10,000 | -24,000 | 249,000 | ||||||||||||||||||||||||||||||||||||||||||||
| minority interests in subsidiary limited partnerships | -1,853,000 | -1,583,000 | -1,977,000 | ||||||||||||||||||||||||||||||||||||||||||||
| income before income taxes from continuing operations | 3,684,000 | 4,166,000 | 4,718,000 | ||||||||||||||||||||||||||||||||||||||||||||
| net income from continuing operations | 2,233,000 | 2,531,000 | 2,855,000 | ||||||||||||||||||||||||||||||||||||||||||||
| discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
| tax benefit (expense) from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
| basic — income from continuing operations | 0.19 | 0.21 | 0.24 | ||||||||||||||||||||||||||||||||||||||||||||
| basic — income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
| total basic earnings per common share | 0.19 | 0.21 | 0.24 | ||||||||||||||||||||||||||||||||||||||||||||
| diluted — income from continuing operations | 0.18 | 0.21 | 0.24 | ||||||||||||||||||||||||||||||||||||||||||||
| diluted — income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
| total diluted earnings per common share | 0.18 | 0.21 | 0.24 | ||||||||||||||||||||||||||||||||||||||||||||
| shares used in computation: | |||||||||||||||||||||||||||||||||||||||||||||||
| basic earnings per common share | 26 | 11,918 | 11,874 | ||||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per common share | 12 | 12,132 | 12,045 | ||||||||||||||||||||||||||||||||||||||||||||
We provide you with 20 years income statements for U.S. Physical Therapy stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of U.S. Physical Therapy stock. Explore the full financial landscape of U.S. Physical Therapy stock with our expertly curated income statements.
The information provided in this report about U.S. Physical Therapy stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.